SOPHARMA AD: Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds

2025-07-10 14:35

publikacja
2025-07-10 14:35

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
SFA_capital_increase_price_correction_10072025_EN_espi.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		81	/	2025
Date of issue:	2025-07-10
Short name of the issuer
SOPHARMA AD
Subject
Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds
Annexes
File			Description
SFA_capital_increase_price_correction_10072025_EN_espi.pdfSFA_capital_increase_price_correction_10072025_EN_espi.pdf			Adjustment of the stock exchange price of the shares of Sopharma AD in connection with the decision to increase the capital with own funds

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2025-07-10	Ognian Donev	Executive Director

Ważne linki